ArticlePeerJ2025
Significance of the inflammatory-immune-nutritional (IINS) score on postoperative survival and recurrence in breast cancer patients: a retrospective study.
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Prognostic value of inflammation-immunity-nutrition score in cancer patients: a meta-analysis.Annals of medicine · 2026Pooled it
- Predicting the prognosis of breast cancer patients by using nutrition-based index: a systematic review and meta-analysis.Frontiers in oncology · 2026Pooled it
- Prognostic value of inflammation-immunity-nutrition score in patients with cancers.Discover oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Inflammation, immune system and nutritional status contribute significantly to tumorigenesis, progression and metastasis. The aim of this study was to evaluate the significance of the inflammation-immune-nutritional score (IINS) on postoperative survival and recurrence in breast cancer patients and to analyze and compare the IINS, platelet-to-lymphocyte ratio (PLR), and the prognostic nutritional index (PNI) in terms of progression-free survival (PFS) and overall survival (OS) in patients with breast cancer (BC) who underwent surgical treatment prognostic value. Methods: We executed a retrospective investigation of the clinical information and related materials of 200 female breast cancer patients who had their first breast cancer operation at the Affiliated Hospital of Jiangnan University between January 2017 and December 2018, and the IINS was built using the sum of preoperative categorical scores for high-sensitivity C-reactive protein (hs-CRP), lymphocytes (LYM), and albumin (ALB). In our survival analysis, we graphed the survival curves employing the Kaplan-Meier method. The effectiveness of pre-operative IINS, PLR, and PNI in PFS and OS of breast cancer patients were evaluated with receiver operating characteristic (ROC) curves and Cox proportional risk regression analyses. Results: The median age of the patients was 55.5 years (range 34-75 years). In progression-free survival, the areas under the IINS, PLR, and PNI curves were as follows: IINS: 0.735, HR (95% CI) 0.037 [0.662-0.809], PLR: 0.724, HR (95% CI) 0.036 [0.655-0.794], PNI: 0.694, HR (95% CI) 0.038 [0.619-0.769]. In overall survival, the areas under the curves of IINS, PLR, and PNI were as follows: IINS: 0.738, HR (95% CI) 0.049 [0.642-0.834], PLR: 0.700, HR (95% CI) 0.039 [0.623-0.777], and PNI: 0.713 with HR (95% CI) 0.050 [0.615-0.811]. According to the findings, among patients with resectable breast cancer, preoperative IINS may be the most accurate indicator of both overall survival and progression-free survival. Conclusion: IINS may be a dependable marker for predicting postoperative survival in patients with breast cancer, and its prognostic value may be higher than that of traditional markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.